6.
Rizo J, Xu J
. The Synaptic Vesicle Release Machinery. Annu Rev Biophys. 2015; 44:339-67.
DOI: 10.1146/annurev-biophys-060414-034057.
View
7.
Diao J, Zhao M, Zhang Y, Kyoung M, Brunger A
. Studying protein-reconstituted proteoliposome fusion with content indicators in vitro. Bioessays. 2013; 35(7):658-65.
PMC: 4453005.
DOI: 10.1002/bies.201300010.
View
8.
Mastronarde D
. Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol. 2005; 152(1):36-51.
DOI: 10.1016/j.jsb.2005.07.007.
View
9.
Brunger A, Leitz J
. The Core Complex of the Ca-Triggered Presynaptic Fusion Machinery. J Mol Biol. 2022; 435(1):167853.
PMC: 10578080.
DOI: 10.1016/j.jmb.2022.167853.
View
10.
Dunn A, Stout K, Ozawa M, Lohr K, Hoffman C, Bernstein A
. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc Natl Acad Sci U S A. 2017; 114(11):E2253-E2262.
PMC: 5358362.
DOI: 10.1073/pnas.1616892114.
View
11.
Kyoung M, Zhang Y, Diao J, Chu S, Brunger A
. Studying calcium-triggered vesicle fusion in a single vesicle-vesicle content and lipid-mixing system. Nat Protoc. 2012; 8(1):1-16.
PMC: 3566647.
DOI: 10.1038/nprot.2012.134.
View
12.
Upmanyu N, Jin J, von der Emde H, Ganzella M, Bosche L, Malviya V
. Colocalization of different neurotransmitter transporters on synaptic vesicles is sparse except for VGLUT1 and ZnT3. Neuron. 2022; 110(9):1483-1497.e7.
DOI: 10.1016/j.neuron.2022.02.008.
View
13.
Tremblay R, Lee S, Rudy B
. GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits. Neuron. 2016; 91(2):260-92.
PMC: 4980915.
DOI: 10.1016/j.neuron.2016.06.033.
View
14.
Tao C, Liu Y, Sun R, Zhang B, Qi L, Shivakoti S
. Differentiation and Characterization of Excitatory and Inhibitory Synapses by Cryo-electron Tomography and Correlative Microscopy. J Neurosci. 2018; 38(6):1493-1510.
PMC: 5815350.
DOI: 10.1523/JNEUROSCI.1548-17.2017.
View
15.
Costa E, Davis J, Dong E, Grayson D, Guidotti A, Tremolizzo L
. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol. 2004; 16(1-2):1-23.
DOI: 10.1615/critrevneurobiol.v16.i12.10.
View
16.
Trimmer J
. Recombinant Antibodies in Basic Neuroscience Research. Curr Protoc Neurosci. 2020; 94(1):e106.
PMC: 7665837.
DOI: 10.1002/cpns.106.
View
17.
Gronborg M, Pavlos N, Brunk I, Chua J, Munster-Wandowski A, Riedel D
. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J Neurosci. 2010; 30(1):2-12.
PMC: 6632534.
DOI: 10.1523/JNEUROSCI.4074-09.2010.
View
18.
Sears S, Hewett S
. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance. Exp Biol Med (Maywood). 2021; 246(9):1069-1083.
PMC: 8113735.
DOI: 10.1177/1535370221989263.
View
19.
Leitz J, Wang C, Esquivies L, Pfuetzner R, Peters J, Couoh-Cardel S
. Beyond the MUN domain, Munc13 controls priming and depriming of synaptic vesicles. Cell Rep. 2024; 43(5):114026.
PMC: 11286359.
DOI: 10.1016/j.celrep.2024.114026.
View
20.
Obata K, Ito M, Ochi R, Sato N
. Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of gamma-aminobutyric acid on deiters NEURONES. Exp Brain Res. 1967; 4(1):43-57.
DOI: 10.1007/BF00235216.
View